McDermott Will & Emery advised GeNeuro on the deal. GeNeuro (Euronext Paris), a biopharmaceutical company developing treatments for neurodegenerative and autoimmune diseases, announced its €7, 7...
You must be a Standard 1 Year member to access this content.
IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised AELIS FARMA with a team including Joseph Marx (Equity Capital Markets),...
You must be a Standard 1 Year member to access this content.
Axipiter advised majority shareholders of Vision Systems, Kramer Levin advised Eurazeo, Gornitzky & CO and McDermott Will & Emery advised Gauzy in the transaction. Israeli company...
You must be a Standard 1 Year member to access this content.
McDermott has advised Acticor Biotech on the offering. Acticor Biotech, a clinical stage biopharmaceutical company dedicated to developing a drug for the treatment of cardiovascular emergencies,...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Bird & Bird, McDermott Will & Emery, advised on the matter. Bird & Bird advised Pixium Vision SA with a team including Emmanuelle Porte...
You must be a Standard 1 Year member to access this content.
